How many email patterns does Locanabio, Inc. use?

Locanabio, Inc. uses 9 known email patterns.

What domain does Locanabio, Inc. use for work emails?

Locanabio, Inc. uses locanabio.com for work email addresses.

Most Common Email Formats at Locanabio, Inc.

Locanabio, Inc.'s most common email format is FLast@locanabio.com (ex. JDoe@locanabio.com), used for 74% of locanabio.com addresses. Locanabio, Inc. uses 4 email patterns.

@locanabio.com

4 patterns

Format	Example	Share of locanabio.com
FLast@locanabio.comMost common	JDoe@locanabio.com	74%
FirstLast@locanabio.com	JohnDoe@locanabio.com	21%
FirstMiddleLast@locanabio.com	JohnMichaelDoe@locanabio.com	3%
Last_First@locanabio.com	Doe_John@locanabio.com	2%

Need a specific person's email?

Browse Locanabio, Inc.'s employee directory (about 7 employees) and reveal verified emails free.

Frequently Asked Questions

What does Locanabio, Inc. do?

Locanabio, Inc. was founded in 2016 and operates in the Biotechnology Research industry, alongside similar companies like Canopy Biosciences, Skyhawk Therapeutics and Ambagon Therapeutics. You can visit locanabio.com. Explore Locanabio, Inc.'s company overview page for more information.

What is Locanabio, Inc.'s email address format?

Locanabio, Inc.'s email format typically follows the pattern of FLast@locanabio.com; this email format is used 74% of the time. Other contacts within LeadIQ's database had email formats such as FirstLast@locanabio.com and FirstMiddleLast@locanabio.com. Looking for more contact data? Unlock accurate emails and phone numbers from millions of profiles verified in real-time.

How many employees does Locanabio, Inc. have currently?

Locanabio, Inc. has approximately 7 employees as of November 2026. Key team members to contact include Chairman: T. D., Senior Vice President, Regulatory Affairs: A. J. and Sr. Director, Head Of Rna Biology & Drug Discovery: D. Z. For more team information and contact data, explore Locanabio, Inc.'s employee directory with LeadIQ.

Locanabio, Inc. Email Format

Biotechnology ResearchCalifornia, United States2-10 Employees

Locanabio is a biotechnology company developing genetic medicines intended to correct the messages produced by disease-causing RNA. Its platform uses gene therapy to deliver RNA-binding modalities that can selectively modulate disease-associated RNA through multiple mechanisms without altering a cell’s DNA. The aim is a durable, single-administration therapy with programs focused on rare genetic neuromuscular and neurodegenerative diseases across various tissues. The company is based in San Diego, California, and operates with a small, science-oriented team within the biotechnology research sector. In October 2023, it announced the launch of a vectorized RNA-targeting platform and presented supporting preclinical data.

Most common format

FLast@locanabio.com

Example: JDoe@locanabio.com

4 patterns. See all formats

Verify a Locanabio, Inc. email address

Free with a LeadIQ account. No credit card.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Most Common Email Formats at Locanabio, Inc.

@locanabio.com

Need a specific person's email?

Frequently Asked Questions

What does Locanabio, Inc. do?

What is Locanabio, Inc.'s email address format?

How many employees does Locanabio, Inc. have currently?

Locanabio, Inc. Email Format

Ready to create more pipeline?

Everything for prospecting,in one platform.

What you can expect from LeadIQ:

Ready to create more pipeline?

Everything for prospecting,
in one platform.